Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population – first results from a cohort study in Southern Sweden

Jonas Björk, Malin Inghammar, Mahnaz Moghaddassi, Magnus Rasmussen, Ulf Malmqvist, Fredrik Kahn
doi: https://doi.org/10.1101/2021.04.20.21254636

Article usage

Article usage: April 2021 to December 2024

AbstractFullPdf
Apr 202159761241648
May 20213505212968
Jun 20211990112450
Jul 20214547241410
Aug 20214733335463
Sep 20211713100223
Oct 2021376695440
Nov 2021143539466
Dec 2021112129153
Jan 2022148138130
Feb 20227553165
Mar 20224632851
Apr 2022318544
May 20223141236
Jun 2022248689
Jul 20222239228
Aug 2022200623
Sep 20222001635
Oct 20222102836
Nov 2022189725
Dec 2022212472
Jan 2023357624
Feb 20231351018
Mar 202312217
Apr 2023138818
May 20238629
Jun 20231301012
Jul 2023117511
Aug 20231392318
Sep 20231321518
Oct 20231143712
Nov 202392514
Dec 202383411
Jan 202410164
Feb 2024871517
Mar 2024831518
Apr 202481179
May 20249879
Jun 20241031014
Jul 2024921115
Aug 20241011524
Sep 2024104815
Oct 202494410
Nov 2024103314
Dec 20246304
Back to top
Posted April 21, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of the BNT162b2 vaccine in preventing COVID-19 in the working age population – first results from a cohort study in Southern Sweden
Jonas Björk, Malin Inghammar, Mahnaz Moghaddassi, Magnus Rasmussen, Ulf Malmqvist, Fredrik Kahn
medRxiv 2021.04.20.21254636; doi: https://doi.org/10.1101/2021.04.20.21254636
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area